Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/CUFENCE 200 MG CAPSULAS DURAS

Approved

STANDARD

CUFENCE 200 MG CAPSULAS DURAS

Univar Solutions B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 6, 2020
Approval ID: 5ce059a0033edf31
Company: Univar Solutions B.V.
Type: Standard

Approval Details

Approval Id: 5ce059a0033edf31
Drug Cima Aemps Name: CUFENCE 200 MG CAPSULAS DURAS
Register Number: 1191365001
Holder Company Name: Univar Solutions B.V.
Marketing Company Name: Waas Anita S.A.
Holder Company Detail Path: /organization/univar-solutions-b-v
Authorization Date: 2020-10-06
Dosage Form: CÁPSULA DURA
Dose: 200 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Univar Solutions B.V.
Company Detail Path: /organization/univar-solutions-b-v

Company Information

Pharmaceutical Company Name: Univar Solutions B.V.
Country Name: Netherlands
City Name: rotterdam,zuid-holland,country_nl
Address: Schouwburgplein 30

Active Ingredients

TRIENTINA DIHIDROCLORURO

300 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 6, 2020

Approval ID

5ce059a0033edf31

Type

Standard

Back to CIMA-AEMPS Approvals

CUFENCE 200 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details